Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology 2024-09-11 06:46
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 2024-09-10 20:00
ICP DAS-BMP Reveals Advanced Engineering TPUs at Medtec China 2024 2024-09-10 09:30
Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation 2024-09-10 08:00
Seegene Expands mpox RUO Product Lineups with Enhanced Detection Assays for Clade 1 2024-09-09 22:15
Sirsram Medical announces NMPA approval for DAXXIFY® 2024-09-09 19:46
A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe 2024-09-09 15:00
Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today 2024-09-09 14:27
ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress 2024-09-09 08:25
Sciwind Biosciences Announces Oral Presentations at the European Association for the Study of Diabetes 60th Annual Meeting (EASD 2024) 2024-09-06 10:10
Chugai Pharma Taiwan wins Social Empowerment and Green Leadership Categories at the Asia Responsible Enterprise Awards 2024 2024-09-05 10:47
Veeva Vault CRM Suite to Unlock Greater Customer Centricity with Launch of Service Center 2024-09-05 09:00
TraceLink's Magnum Release of its Opus Platform Will Revolutionize Supply Chain Management by Enabling All Businesses to Digitalize their End-to-End Supply Networks 2024-09-04 22:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma 2024-09-04 08:00
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 2024-09-04 06:57
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays 2024-09-02 21:00
Frost & Sullivan Released Report: "BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies" 2024-09-02 17:20
Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024 2024-09-02 08:23
Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI®(encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation 2024-08-30 20:44
1 6 7 8 9 10 247